Product News: Enable low abundant TH17 pathway biomarker monitoring

01 Nov 2012

Leveraging TH17 pathway biomarkers in immune mediated inflammatory diseases is highly challenging due to their low abundance. High-definition Erenna® technology’s powerful suite of TH17 pathway immunoassay kits, with LLoQ down to the sub pictogram levels, offers researchers unique and novel insights, enabling quicker and more confident decision making.